28 Jan Acute Hepatic Porphyria (AHP)
Author: Dr. Joanne Britto, McMaster University.
Reviewer: Dr. Menaka Pai, Associate Professor, Division of Hematology & Thromboembolism, Department of Medicine, McMaster University
Objectives
At the end of the self-assessment module, participants will be able to:
1. Identify the clinical manifestations of acute hepatic porphyria (AHP)
2. Describe the pathophysiology of AHP.
3. Explain how to evaluate a patient with suspected AHP.
4. Describe the management of a patient with AHP.
CHS Scientific Planning Committee Members (2021-22)
Dr. Joanne Britto – Resident Physician, Hematology-Oncology
Dr. Yan Xu – Fellow Physician, Hematology
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre
Conflicts of Interest: None